Cited by 182Vagus Nerve Stimulation ResearchNeuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments

Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice

Open access
Huffman, William J., Subramaniyan, Saraswathi, Rodriguiz, Ramona M., Wetsel, William C., Grill, Warren M., Terrando, Niccolò·2019·Brain Stimulation

Abstract

BACKGROUND: The vagus nerve is involved in regulating immunity and resolving inflammation. Current strategies aimed at modulating neuroinflammation and cognitive decline, in many cases, are limited and ineffective. OBJECTIVE: We sought to develop a minimally invasive, targeted, vagus nerve stimulation approach (pVNS), and we tested its efficacy with respect to microglial activation and amelioration of cognitive dysfunction following lipopolysaccharide (LPS) endotoxemia in mice. METHODS: We stimulated the cervical vagus nerve in mice using an ultrasound-guided needle electrode under sevoflurane anesthesia. The concentric bipolar needle electrode was percutaneously placed adjacent to the carotid sheath and stimulation was verified in real-time using bradycardia as a biomarker. Activation of vagal fibers was confirmed with immunostaining in relevant brainstem structures, including the dorsal motor nucleus and nucleus tractus solitarius. Efficacy of pVNS was evaluated following administration of LPS and analyses of changes in inflammation and behavior. RESULTS: pVNS enabled stimulation of the vagus nerve as demonstrated by changes in bradycardia and histological evaluation of c-Fos and choline acetyltransferase expression in brainstem nuclei. Following LPS administration, pVNS significantly reduced plasma levels of tumor necrosis factor-α at 3 h post-injection. pVNS prevented LPS-induced hippocampal microglial activation as analyzed by changes in Iba-1 immunoreactivity, including cell body enlargement and shortened ramifications. Cognitive dysfunction following endotoxemia was also restored by pVNS. CONCLUSION: Targeted cervical VNS using this novel percutaneous approach reduced LPS-induced systemic and brain inflammation and significantly improved cognitive responses. These results provide a novel therapeutic approach using bioelectronic medicine to modulate neuro-immune interactions that affect cognition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brs.2018.10.005

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Peripheral inflammation triggers central cytokine release via vagus nerve-mediated signal transduction, forming a vicious neuro-immune cycle.

    “Peripheral inflammation triggers central cytokine release via vagus nerve-mediated signal transduction, forming a vicious neuro-immune cycle [94].”

    From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [94]

    The Introduction (page unavailable) says systemic endotoxemia induces pro-inflammatory cytokines and changes in brain microglia, and that a vagal circuit relays information about peripheral inflammation to the brain. The Discussion (page unavailable) describes that circuit as anti-inflammatory. Neither section establishes that vagal signaling triggers central cytokine release or forms a self-reinforcing neuro-immune cycle. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Cholinergic system dysfunction leads to dysregulated microglial activation thresholds and accelerated transformation towards neurotoxic phenotypes.

    “Cholinergic system dysfunction is manifested by reduced ChAT-positive neurons and abnormal AChE activity, leading to dysregulated microglial activation thresholds and accelerated transformation towards neurotoxic phenotypes [94].”

    From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [94]

    The Discussion reports that cholinergic agonists can affect microglial activation, and the Results show reduced microglial activation after vagus nerve stimulation in LPS-treated mice. Neither section establishes that cholinergic dysfunction changes microglial activation thresholds or accelerates a shift to neurotoxic phenotypes. The paper also does not report reduced ChAT-positive neurons or abnormal AChE activity as manifestations of dysfunction. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Cholinergic system dysfunction in SAE is manifested by abnormal AChE activity.

    “Cholinergic system dysfunction is manifested by reduced ChAT-positive neurons and abnormal AChE activity, leading to dysregulated microglial activation thresholds and accelerated transformation towards neurotoxic phenotypes [94].”

    From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [94]

    The Results section on brainstem activity reports increased c-Fos/ChAT-positive cells after vagus nerve stimulation, not abnormal AChE activity. The Discussion addresses cholinergic signaling and microglial activation, but no passage found addresses AChE activity as a manifestation of cholinergic dysfunction in SAE (searched: AChE, acetylcholinesterase, SAE). Page numbers were not available in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Cholinergic system dysfunction in SAE is manifested by reduced ChAT-positive neurons.

    “Cholinergic system dysfunction is manifested by reduced ChAT-positive neurons and abnormal AChE activity, leading to dysregulated microglial activation thresholds and accelerated transformation towards neurotoxic phenotypes [94].”

    From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [94]

    The Results section reports increased c-Fos/ChAT-double-positive cells after vagus nerve stimulation, a measure of cholinergic neuronal activation. Neither that passage nor the Discussion reports reduced ChAT-positive neuron numbers in sepsis-associated encephalopathy; searches for that finding and for abnormal AChE activity found no supporting passage. Page numbers were unavailable in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Huffman, W. J., Subramaniyan, S., Rodriguiz, R. M., Wetsel, W. C., Grill, W. M., & Terrando, N.
Affiliations
Duke University (US)
Corresponding author
Terrando, Niccolò
Venue
Brain Stimulation
Publisher
Elsevier BV
Published
2019-01
Volume
12
Issue
1
Pages
19-29
ISSN
  • 1876-4754 (ISSN-L)
  • 1935-861X
OpenAlex
W2897533172
Cited by
181
References
49
Citations by year
2026: 17 · 2025: 27 · 2024: 22 · 2023: 29 · 2022: 33 · 2021: 24 · 2020: 18 · 2019: 11
FWCI
5.94
Type
journal article
Language
en
Open access
Locations
  • Brain stimulation (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute on Aging (R21AG055877, R01AG057525)
Topics
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
neuroinflammation, memory impairment, microglial activation, hippocampus, bioelectronic medicine, neuroimmune interactions, TNF-α, dorsal motor nucleus of the vagus, nucleus tractus solitarius, cognitive impairment
MeSH terms
Animals, Inflammation, Lipopolysaccharides, Male, Cytokines, Solitary Nucleus, Endotoxemia, Mice, Vagus Nerve Stimulation, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review